Out of Specification
Showing 1 - 25 of >10,000
Large B-cell Lymphoma, Follicular Lymphoma Trial (Axicabtagene Ciloleucel)
Available
- Large B-cell Lymphoma
- Follicular Lymphoma
- Axicabtagene Ciloleucel
- (no location specified)
Mar 17, 2023
Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial (Brexucabtagene Autoleucel)
Available
- Mantle Cell Lymphoma
- Acute Lymphoblastic Leukemia
- Brexucabtagene Autoleucel
- (no location specified)
Mar 17, 2023
Multiple Myeloma Trial (Cilta-cel OOS Therapy)
Available
- Multiple Myeloma
- Cilta-cel OOS Therapy
- (no location specified)
Aug 15, 2022
Multiple Myeloma Trial in United States (Cilta-cel, Lymphodepleting Therapy (Cyclophosphamide and Fludarabine))
Recruiting
- Multiple Myeloma
- Cilta-cel
- Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
-
Duarte, California
- +23 more
Aug 1, 2022
B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma Trial in Canada, Japan (CTL019)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Diffuse Large B-cell Lymphoma
- CTL019
-
Hamilton, Ontario, Canada
- +41 more
Oct 17, 2022
Rhizarthrosis Trial in Champigny-sur-Marne (collecting a Nanofat-type microfat autograft)
Completed
- Rhizarthrosis
- collecting a Nanofat-type microfat autograft
-
Champigny-sur-Marne, FranceHôpital Privé Paul d'Egine
Jun 22, 2023
Epileptic Seizures Related to Drugs Trial in Xi'an (minocycline)
Enrolling by invitation
- Epileptic Seizures Related to Drugs
-
Xi'an, Shaanxi, ChinaXijingHospital
Jul 21, 2023
Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome Trial in Denmark (Dexamethasone, Backrest elevation, Early wakeup
Not yet recruiting
- Out-Of-Hospital Cardiac Arrest
- Post-Cardiac Arrest Syndrome
- Dexamethasone
- +3 more
-
Copenhagen, Capital Region Of Denmark, Denmark
- +4 more
Jun 7, 2023
Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin
Not yet recruiting
- Pain
- Insomnia
- Compound ibuprofen polyrelease tablets
- reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Feb 6, 2023
Coronary Artery Disease, Intravascular Lithotripsy Trial in China (Intracoronary lithotripsy balloon catheter and Intracoronary
Not yet recruiting
- Coronary Artery Disease
- Intravascular Lithotripsy
- Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus
- Dragonfly Opstar Imaging Catheter
-
Guangzhou, Guangdong, China
- +19 more
Dec 13, 2022
Suture Techniques, Medical Glue Trial in Xiamen (Dermal barb suture combined with medical glue)
Completed
- Suture Techniques
- Medical Glue
- Dermal barb suture combined with medical glue
-
Xiamen, Fujian, ChinaYizhuo Lu
Mar 22, 2023
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Active, not recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +110 more
Jan 23, 2023
Epilepsy Trial in Wuhan (Lacosamide Tablets, Lacosamide extended release tablets)
Not yet recruiting
- Epilepsy
- Lacosamide Tablets
- Lacosamide extended release tablets
-
Wuhan, Hubei, ChinaUnion Hospital of Tongji Medical College of Huazhong University
Mar 15, 2023
Hypertension Trial in Guangdong (Amlodipine besylate tablets (trade name: Norfloxacin ®), Amlodipine besylate controlled-release
Not yet recruiting
- Hypertension
- Amlodipine besylate tablets (trade name: Norfloxacin ®）
- Amlodipine besylate controlled-release tablets
-
Guangdong, Guangzhou, ChinaZhujiang Hospital of Southern Medical University
Jan 3, 2023
da Vinci SP Surgical System for Single-Port Colorectal
Recruiting
- Single-Port Colorectal Surgeries
- procedure
-
Shanghai, Shanghai, ChinaRuijin Hospital
Nov 15, 2023
EVEREST-HN 1: EVolution ofpatiEnt-REported Symptom-based Risk
Recruiting
- Head and Neck Cancer
- No intervention.
-
Leeds, United Kingdom
- +3 more
Jun 14, 2023
Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets
Active, not recruiting
- Partial Seizure
- Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Municipal People's Hospital
Jan 31, 2023
Cervicogenic Dizziness Trial in Shanghai (Shi's traumatology osteopathic manipulation, Merislon)
Not yet recruiting
- Cervicogenic Dizziness
- Shi's traumatology osteopathic manipulation
- Merislon
-
Shanghai, Shanghai, China
- +3 more
Oct 31, 2022
NSCLC Metastatic Trial in Shanghai (Almonertinib, SBRT)
Recruiting
- Non-small Cell Lung Cancer Metastatic
- Almonertinib
- SBRT
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 23, 2023
Thrombocytopenia, Transfusion Trial in Dublin (Dose of platelet transfusion)
Not yet recruiting
- Thrombocytopenia
- Transfusion
- Dose of platelet transfusion
-
Dublin, IrelandNational Maternity Hospital
Oct 18, 2023
Cadmium Exposure Trial in Changsha (GMDTC for injection, Normal saline)
Recruiting
- Cadmium Exposure
- GMDTC for injection
- Normal saline
-
Changsha, Hunan, ChinaHunan Occupational Disease Prevention and Control Institute
Jun 9, 2023
Respiratory Distress Syndrome Trial in Bern (NHF high, NHF low, NCPAP)
Not yet recruiting
- Respiratory Distress Syndrome
- NHF high
- +2 more
-
Bern, SwitzerlandDepartment of Pediatrics, Inselspital
Jun 8, 2023
Bortezomib, Acute Myeloid Leukemia Trial in Wuhan (DAG pre-excitation regimen with Bortezomib)
Recruiting
- Bortezomib
- Acute Myeloid Leukemia
- DAG pre-excitation regimen with Bortezomib
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 31, 2023
Validation of the Mjn-SERAS Performance
Not yet recruiting
- Performance Enhancing Product Use
- Quality of Life
- mjn-SERAS
- (no location specified)
Apr 25, 2023
Ondexxya for Intravenous Injection 200mg Drug Use Result
Recruiting
- Life Threatening Bleeding
- Factor Xa Inhibitor
-
Tokyo, JapanResearch Site
Jul 7, 2022